680
Views
15
CrossRef citations to date
0
Altmetric
Original Articles: Research

Patterns of treatment and costs associated with transfusion burden in patients with myelodysplastic syndromes

, , , , , , & show all
Pages 2649-2656 | Received 29 Nov 2016, Accepted 14 Mar 2017, Published online: 09 May 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Carlo Finelli, Sarah Parisi & Stefania Paolini. (2022) Exploring the rationale for red cell transfusion in myelodysplastic syndrome patients: emerging data and future insights. Expert Review of Hematology 15:5, pages 411-421.
Read now
Jill A. Bell, Aaron Galaznik, Marlo Blazer, Eileen Farrelly, Augustina Ogbonnaya, Aditya Raju, Michael Eaddy, Robert J. Fram & Douglas V. Faller. (2019) Transfusion-free interval is associated with improved survival in patients with higher-risk myelodysplastic syndromes engaged in routine care. Leukemia & Lymphoma 60:1, pages 49-59.
Read now

Articles from other publishers (13)

Jessica M. Stempel, Zhuoer Xie, Jan Philipp Bewersdorf, Maximilian Stahl & Amer M. Zeidan. (2023) Evolution of Therapeutic Benefit Measurement Criteria in Myelodysplastic Syndromes/Neoplasms. The Cancer Journal 29:3, pages 203-211.
Crossref
Jessica M. Stempel, Nikolai A. Podoltsev & Talib Dosani. (2023) Supportive Care for Patients With Myelodysplastic Syndromes. The Cancer Journal 29:3, pages 168-178.
Crossref
Valeria Santini, Aristoteles Giagounidis, Christopher G. Pelligra, Conrado Franco-Villalobos, Derek Tang, Jessica Morison, CL Beach, Angela Hu, Uwe Platzbecker & Pierre Fenaux. (2022) Impact of Lenalidomide Treatment on Overall Survival in Patients With Lower-Risk, Transfusion-Dependent Myelodysplastic Syndromes. Clinical Lymphoma Myeloma and Leukemia 22:9, pages e874-e883.
Crossref
Claire Jouzier, Amina Cherait, Pascale Cony‐Makhoul, Jean‐François Hamel, Melanie Veloso, Sylvain Thepot, Thomas Cluzeau, Aspasia Stamatoullas, Alice Garnier, Agnès Guerci‐Bresler, Sophie Dimicoli‐Salazar, Gian Matteo Pica, Stéphane Cheze, Clémence Santana, Fatiha Chermat, Pierre Fenaux & Sophie Park. (2022) Red blood cell transfusion burden in myelodysplastic syndromes ( MDS ) with ring Sideroblasts ( RS ): A retrospective multicenter study by the Groupe Francophone des Myélodysplasies ( GFM ) . Transfusion 62:5, pages 961-973.
Crossref
Shaima Kaka, Ashkan Jahangirnia, Nickolas Beauregard, Alexandra Davis, Alan Tinmouth & Nicolas Chin‐Yee. (2021) Red blood cell transfusion in myelodysplastic syndromes: A systematic review. Transfusion Medicine 32:1, pages 3-23.
Crossref
Aaron T. Gerds, Prithviraj Bose, Gabriela S. Hobbs, Andrew T. Kuykendall, Lynn M. Neilson, Jinlin Song, Barbara Klencke & Claire N. Harrison. (2022) Treating Anemic Patients With Myelofibrosis in the New Janus Kinase Inhibitor Era: Current Evidence and Real-world Implications. HemaSphere 6:10, pages e778.
Crossref
Esther N. Oliva, Uwe Platzbecker, Pierre Fenaux, Guillermo Garcia-Manero, Thomas W. LeBlanc, Bhumika J. Patel, Anne Sophie Kubasch & Mikkael A. Sekeres. (2021) Targeting health-related quality of life in patients with myelodysplastic syndromes – Current knowledge and lessons to be learned. Blood Reviews 50, pages 100851.
Crossref
Mayra Braga Lemos, Sarah Ramalho Rodrigues, Thomas Schroeder, Austin G. Kulasekararaj, Joana E. Matos & Derek Tang. (2021) Association between red blood cell transfusion dependence and burden in patients with myelodysplastic syndromes: A systematic literature review and meta‐analysis. European Journal of Haematology 107:1, pages 3-23.
Crossref
Erica M. Wood & Zoe K. McQuilten. (2020) Outpatient transfusions for myelodysplastic syndromes. Hematology 2020:1, pages 167-174.
Crossref
Ulrich Germing, Ester N. Oliva, Devendra Hiwase & Antonio Almeida. (2019) Treatment of Anemia in Transfusion-Dependent and Non-Transfusion-Dependent Lower-Risk MDS: Current and Emerging Strategies. HemaSphere 3:6, pages e314.
Crossref
Lindsay Wilde & Jonathan Pan. (2019) Restrictive Versus Liberal Transfusion Strategies in Myelodysplastic Syndrome and Beyond. Clinical Lymphoma Myeloma and Leukemia 19:12, pages 758-762.
Crossref
Amer M. Zeidan, Rory M. Shallis, Rong Wang, Amy Davidoff & Xiaomei Ma. (2019) Epidemiology of myelodysplastic syndromes: Why characterizing the beast is a prerequisite to taming it. Blood Reviews 34, pages 1-15.
Crossref
Jonathan Slack, Leonard Nguyen, Christopher Naugler & Fariborz Rashid-Kolvear. (2018) Incidence of Myelodysplastic Syndromes in a Major Canadian Metropolitan Area. The Journal of Applied Laboratory Medicine 3:3, pages 378-383.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.